VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,000 | -44.7% | 65,200 | -14.2% | 0.00% | -33.3% |
| Q2 2023 | $1,808 | +98.5% | 76,000 | +112.3% | 0.00% | +200.0% |
| Q1 2023 | $911 | -100.0% | 35,800 | -64.8% | 0.00% | -66.7% |
| Q3 2022 | $2,084,000 | +843.0% | 101,600 | +667.4% | 0.00% | – |
| Q1 2021 | $221,000 | – | 13,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 944,092 | $15,530,000 | 5.65% |
| Ally Bridge Group (NY) LLC | 904,978 | $14,887,000 | 4.38% |
| COMMODORE CAPITAL LP | 667,674 | $10,983,000 | 2.90% |
| FRAZIER MANAGEMENT LLC | 1,505,200 | $24,761,000 | 1.98% |
| Logos Global Management LP | 1,500,000 | $24,675,000 | 1.78% |
| Ghost Tree Capital, LLC | 350,000 | $5,758,000 | 1.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 106,078 | $1,745,000 | 0.99% |
| Vivo Capital, LLC | 1,300,000 | $21,385,000 | 0.96% |
| ACUTA CAPITAL PARTNERS, LLC | 135,807 | $2,234,000 | 0.79% |
| BVF INC/IL | 804,126 | $13,228,000 | 0.52% |